A rare genetic condition may be causing your progressive kidney decline. Learn what Fabry disease is, what causes it, and how it’s treated.
Fabry disease is a genetic disorder that can damage your nerves and major organs, including your kidneys. Though rare, Fabry disease can affect several members of a single family. In a recent presentation by the American Kidney Fund, Dr. Michael Mauer, a pediatric nephrologist at the University of Minnesota, explained what Fabry disease is and how you can find out if it may be the cause of your kidney problems.*
Fabry disease results from a mutation in a gene, known as the GLA gene, on your X chromosome. The GLA gene provides instructions for making the alpha galactosidase A enzyme, which breaks down a fatty substance called globotriaosylceramide. The mutated gene prevents or reduces the production of alpha galactosidase A. Without this enzyme, globotriaosylceramide doesn’t break down and instead, the fatty substance accumulates in blood vessels and tissues throughout your body.
Fabry is heterogeneous, meaning that it affects people differently. Since males have only one X-chromosome, a mutated gene means that they will almost definitely get the disease, and most likely the severe, classic form of it. Females have two X-chromosomes, so a mutated gene may result in a milder form of the disease. In rare cases, a woman may not experience symptoms at all. Males with classic Fabry disease are at high risks of injury to vital organs.
Signs and symptoms of Fabry disease usually manifest as:
As with its signs and symptoms, Fabry disease can also cause complications across multiple body systems and may include:
Fabry disease is diagnosed using a combination of:
The disease may be diagnosed by a dermatologist, neurologist, nephrologist, ophthalmologist, or other specialist.
The disease is most often treated with enzyme replacement therapy (ERT). In the United States, this takes the form of agalsidase beta (brand name Fabrazyme), manufactured by Sanofi-Genzyme. The treatment is administered by intravenous infusion, usually every two weeks. There is also an oral therapy called migalastat (brand name Galafold), which is given in capsule form every other day.
Several other treatments are being explored in clinical trials, including a plant-based ERT called Protolix, and several forms of gene therapy.
*American Kidney Fund. (2021, Apr. 21). The Link Between Fabry Disease and Your Kidneys [Video]. https://www.kidneyfund.org/training/webinars/the-link-between-fabry-disease-and-your-kidneys.html
Source: {{articlecontent.article.sourceName}}
Receive daily updated expert-reviewed article summaries. Everything you need to know from discoveries, treatments, and living tips!
Already a Responsum member?
Available for Apple iOS and Android
Add Comments
Cancel